Privia Health Group, Inc. (PRVA) Earnings History
Turnaround8 years of earnings data (2018–2025) · Recovering earnings after a multi-year decline
Loading earnings history...
Privia Health Group, Inc. (PRVA) Earnings Overview
As of October 3, 2026, Privia Health Group, Inc. (PRVA) reported trailing twelve-month net income of $28M, reflecting +63.6% year-over-year growth. The company earned $0.21 per diluted share over the past four quarters, with a net profit margin of 1.1%.
Looking at the long-term picture, PRVA's 5-year EPS compound annual growth rate (CAGR) stands at -9.7%, signaling declining earnings. The company achieved its highest annual net income of $31M in fiscal 2020.
Privia Health Group, Inc. maintains positive profitability with a gross margin of 9.9%, operating margin of 1.6%, and net margin of 1.1%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including AGIO (-$411M net income, -764.0% margin), CNC (-$5.10B net income, -3.4% margin), ALHC ($41M net income, -0.0% margin), PRVA has outperformed on profitability metrics. Compare PRVA vs AGIO →
PRVA Earnings vs Peers
Earnings metrics vs comparable public companies
PRVA Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $23M | +59.3% | $34M | $0.18 | 1.1% | 1.6% |
| 2024 | $14M | -37.7% | $17M | $0.11 | 0.8% | 1.0% |
| 2023 | $23M | +368.8% | $21M | $0.19 | 1.4% | 1.2% |
| 2022 | -$9M | +95.4% | -$19M | $-0.08 | -0.6% | -1.4% |
| 2021 | -$188M | -702.5% | -$217M | $-1.77 | -19.5% | -22.5% |
| 2020 | $31M | +279.0% | $25M | $0.30 | 3.8% | 3.1% |
| 2019 | $8M | +370.8% | $16M | $0.08 | 1.0% | 2.0% |
| 2018 | -$3M | - | $2M | $-0.03 | -0.5% | 0.3% |
Download Data
Export PRVA earnings history in CSV or JSON format
Free sign-in required to download data
PRVA Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
8+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PRVA — Frequently Asked Questions
Quick answers to the most common questions about buying PRVA stock.
What is PRVA earnings per share (EPS)?
PRVA trailing twelve-month (TTM) diluted EPS is $0.21, reflecting +63.6% year-over-year growth. The 5-year EPS CAGR is -9.7%. Complete EPS history from 2018 to 2025 is available in the table on this page.
What is Privia Health Group, Inc.'s net income?
Privia Health Group, Inc. (PRVA) trailing twelve-month net income is $28M as of 2025. Earnings grew +63.6% year-over-year. Privia Health Group, Inc. has been profitable for 3 consecutive years.
Is PRVA profitable?
Yes, PRVA is profitable with a TTM net income of $28M and a net profit margin of +1.1%. Privia Health Group, Inc. has generated profits for 3 consecutive years.
What is PRVA's earnings growth rate?
PRVA compound annual EPS growth rates (CAGR): 1-Year: +63.6%, 3-Year: N/A, 5-Year: -9.7%, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2018 to 2025.
What are PRVA's profit margins?
Privia Health Group, Inc. net profit margin is +1.1%, operating margin is +1.6%, and gross margin is +9.9%. Below-average margins reflect competitive or cost pressures. Return on Equity is +3.1%.
Is PRVA growing earnings?
Yes, PRVA earnings are accelerating — EPS growth of +63.6% exceeds the 5-year CAGR of -9.7%. TTM net income reached $28M. Earnings momentum is strengthening.
What was PRVA's best earnings year?
Privia Health Group, Inc.'s highest annual net income on record is $31M, achieved in fiscal year 2020. Earnings history on this page spans 2018 to 2025 and includes all annual and quarterly figures.
What were PRVA's earnings last quarter?
PRVA's most recent reported quarter was Q2 2026. Net income was $9M with diluted EPS of $0.07. For a full breakdown of all quarters, see the quarterly earnings table on this page.